Inclisiran inhibits hepatic synthesis of proprotein convertase subtilisin–kexin type 9. Previous studies suggest that inclisiran might provide sustained reductions in low-density lipoprotein (LDL) ...
The pathophysiology of ischemic stroke is thought to be very similar to that of atherosclerosis. They share many common risk factors and treatments, and are often grouped into a single entity: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results